AKOUOS, INC.

AKUS
Delayed Nasdaq - 04:00 2022-11-30 pm EST
13.29 USD +1.06%

Turn to zoom
Prev.13.29000000
Open13.20000000
High13.33000000
Low13.16000000
Volume1 790 496
Latest news
3d ago
3d ago
3d ago
3d ago
Chart AKOUOS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance13,513,513,4
Spread/Res.-1,6%-1,6%-0,75%
Spread/Supp.1,2%95%124%
Support13,16,835,94
Financials
Sales 2022 - - -
Net income 2022 -99,3 M - -
Net Debt 2022 - - -
P/E ratio 2022 -5,60x
Yield 2022 -
Capitalization 491 M 491 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 103
Free-Float 98,9%
Company
Akouos Inc. precision genetic medicine company focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals. The Company is focused on developing precision therapies for forms of sensorineural hearing loss. The Company's...
Sector :
Bio Therapeutic Drugs
Calendar :
2023-03-28 Earnings Release

Income Statement Evolution